Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Cells ; 13(11)2024 May 30.
Article in English | MEDLINE | ID: mdl-38891076

ABSTRACT

Pacemaking activity in substantia nigra dopaminergic neurons is generated by the coordinated activity of a variety of distinct somatodendritic voltage- and calcium-gated ion channels. We investigated whether these functional interactions could arise from a common localization in macromolecular complexes where physical proximity would allow for efficient interaction and co-regulations. For that purpose, we immunopurified six ion channel proteins involved in substantia nigra neuron autonomous firing to identify their molecular interactions. The ion channels chosen as bait were Cav1.2, Cav1.3, HCN2, HCN4, Kv4.3, and SK3 channel proteins, and the methods chosen to determine interactions were co-immunoprecipitation analyzed through immunoblot and mass spectrometry as well as proximity ligation assay. A macromolecular complex composed of Cav1.3, HCN, and SK3 channels was unraveled. In addition, novel potential interactions between SK3 channels and sclerosis tuberous complex (Tsc) proteins, inhibitors of mTOR, and between HCN4 channels and the pro-degenerative protein Sarm1 were uncovered. In order to demonstrate the presence of these molecular interactions in situ, we used proximity ligation assay (PLA) imaging on midbrain slices containing the substantia nigra, and we could ascertain the presence of these protein complexes specifically in substantia nigra dopaminergic neurons. Based on the complementary functional role of the ion channels in the macromolecular complex identified, these results suggest that such tight interactions could partly underly the robustness of pacemaking in dopaminergic neurons.


Subject(s)
Dopaminergic Neurons , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels , Mesencephalon , Proteomics , Small-Conductance Calcium-Activated Potassium Channels , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels/metabolism , Proteomics/methods , Dopaminergic Neurons/metabolism , Animals , Small-Conductance Calcium-Activated Potassium Channels/metabolism , Mesencephalon/metabolism , Humans , Calcium Channels, L-Type/metabolism , Mice , Substantia Nigra/metabolism
2.
Sci Rep ; 8(1): 13637, 2018 09 11.
Article in English | MEDLINE | ID: mdl-30206240

ABSTRACT

Most neuronal types have a well-identified electrical phenotype. It is now admitted that a same phenotype can be produced using multiple biophysical solutions defined by ion channel expression levels. This argues that systems-level approaches are necessary to understand electrical phenotype genesis and stability. Midbrain dopaminergic (DA) neurons, although quite heterogeneous, exhibit a characteristic electrical phenotype. However, the quantitative genetic principles underlying this conserved phenotype remain unknown. Here we investigated the quantitative relationships between ion channels' gene expression levels in midbrain DA neurons using single-cell microfluidic qPCR. Using multivariate mutual information analysis to decipher high-dimensional statistical dependences, we unravel co-varying gene modules that link neurotransmitter identity and electrical phenotype. We also identify new segregating gene modules underlying the diversity of this neuronal population. We propose that the newly identified genetic coupling between neurotransmitter identity and ion channels may play a homeostatic role in maintaining the electrophysiological phenotype of midbrain DA neurons.


Subject(s)
Dopaminergic Neurons/metabolism , Gene Expression Regulation/genetics , Ion Channels/genetics , Neurotransmitter Agents/genetics , Animals , Dopamine/genetics , Dopamine/metabolism , Electrophysiological Phenomena , Ion Channels/metabolism , Mesencephalon/metabolism , Mice , Mice, Transgenic , Neurotransmitter Agents/metabolism , Substantia Nigra/metabolism , Ventral Tegmental Area/metabolism
3.
Stem Cells Transl Med ; 3(12): 1467-72, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25355730

ABSTRACT

For years, our ability to study pathological changes in neurological diseases has been hampered by the lack of relevant models until the recent groundbreaking work from Yamanaka's group showing that it is feasible to generate induced pluripotent stem cells (iPSCs) from human somatic cells and to redirect the fate of these iPSCs into differentiated cells. In particular, much interest has focused on the ability to differentiate human iPSCs into neuronal progenitors and functional neurons for relevance to a large number of pathologies including mental retardation and behavioral or degenerative syndromes. Current differentiation protocols are time-consuming and generate limited amounts of cells, hindering use on a large scale. We describe a feeder-free method relying on the use of a chemically defined medium that overcomes the need for embryoid body formation and neuronal rosette isolation for neuronal precursors and terminally differentiated neuron production. Four days after induction, expression of markers of the neurectoderm lineage is detectable. Between 4 and 7 days, neuronal precursors can be expanded, frozen, and thawed without loss of proliferation and differentiation capacities or further differentiated. Terminal differentiation into the different subtypes of mature neurons found in the human brain were observed. At 6-35 days after induction, cells express typical voltage-gated and ionotrophic receptors for GABA, glycine, and acetylcholine. This specific and efficient single-step strategy in a chemically defined medium allows the production of mature neurons in 20-40 days with multiple applications, especially for modeling human pathologies.


Subject(s)
Cell Differentiation , Induced Pluripotent Stem Cells/cytology , Neural Stem Cells/metabolism , Neurons/cytology , Cell Culture Techniques , Embryoid Bodies/cytology , Embryoid Bodies/metabolism , Humans , Induced Pluripotent Stem Cells/metabolism , Neural Stem Cells/cytology , Neurons/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...